Cargando…

Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects females more than males, with African Americans developing more severe manifestation of the disease. SLE patients are at increased risk for cardiovascular disease (CVD), and SLE women 35-44 years old have 50 fold the inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammad, Samar M., Harden, Olivia C., Wilson, Dulaney A., Twal, Waleed O., Nietert, Paul J., Oates, Jim C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335560/ https://www.ncbi.nlm.nih.gov/pubmed/34367153 http://dx.doi.org/10.3389/fimmu.2021.694318

Ejemplares similares

Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity
por: Hammad, Samar M., et al.
Publicado: (2019)

Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
por: Harden, Olivia C., et al.
Publicado: (2020)

Periodontitis is associated with higher subclinical atherosclerosis in patients with systemic lupus erythematosus
por: Zamora‐Pasadas, Mónica, et al.
Publicado: (2022)

Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus
por: Medeiros, Priscila B. S., et al.
Publicado: (2021)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
por: Rezaieyazdi, Zahra, et al.
Publicado: (2021)

Nocturnal blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus
por: Chang, Joyce C., et al.
Publicado: (2020)

Aortic Atherosclerosis in Systemic Lupus Erythematosus
por: Roldan, Paola C, et al.
Publicado: (2014)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023)

The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus
por: García-Carrasco, Mario, et al.
Publicado: (2018)

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
por: Teixeira, Vítor, et al.
Publicado: (2018)

Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
por: Canpolat, Nur, et al.
Publicado: (2011)

Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis
por: Tan, Sock Hwee, et al.
Publicado: (2021)

Assessment of plasma ceramides as predictor for subclinical atherosclerosis
por: Mishra, Pashupati P., et al.
Publicado: (2021)

Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
por: Dziedzic-Oleksy, Hanna, et al.
Publicado: (2022)

Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications
por: Hammad, Samar M., et al.
Publicado: (2023)

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
por: Martin, Myriam, et al.
Publicado: (2017)

Sphingolipids in Atherosclerosis: Chimeras in Structure and Function
por: Peters, Lisa, et al.
Publicado: (2022)

Plasma IL-5 concentration and subclinical carotid atherosclerosis
por: Silveira, Angela, et al.
Publicado: (2015)

Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
por: Somers, Emily C., et al.
Publicado: (2012)

Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic lupus erythematosus
por: Shehata, Ghaydaa A, et al.
Publicado: (2010)

Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features
por: Mohamed, Alaa A. A., et al.
Publicado: (2019)

Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
por: Mimier-Janczak, Małgorzata Karolina, et al.
Publicado: (2023)

Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus
por: BALCI, Mehmet Ali, et al.
Publicado: (2021)

Gastrointestinal Manifestations in Patients with Systemic Lupus Erythematosus
por: Alharbi, Samar
Publicado: (2022)

Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019)

Subclinical Corneal Nerve Fiber Damage and Immune Cell Activation in Systemic Lupus Erythematosus: A Corneal Confocal Microscopy Study
por: Bitirgen, Gulfidan, et al.
Publicado: (2021)

Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity
por: Rondaan, C, et al.
Publicado: (2018)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus
por: Vázquez-Del Mercado, Mónica, et al.
Publicado: (2018)

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study
por: Chevli, Parag Anilkumar, et al.
Publicado: (2021)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018)

Establishing a Risk Prediction Model for Atherosclerosis in Systemic Lupus Erythematosus
por: Xing, Haiping, et al.
Publicado: (2021)

Soluble E-selectin may predict progression of subclinical atherosclerosis, as measured by coronary artery calcium score and aorta calcium score, in women with systemic lupus erythematosus
por: Lertratanakul, A, et al.
Publicado: (2012)

Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus
por: Mahieu, MA, et al.
Publicado: (2012)

The Complex Tail of Circulating Sphingolipids in Atherosclerosis and Cardiovascular Disease
por: Zelnik, Iris D., et al.
Publicado: (2021)

Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins
por: Hammad, Samar M., et al.
Publicado: (2020)

Relationship Between Systemic Lupus Erythematosus Disease Activity Index Scores and Subclinical Cardiac Problems
por: Mirfeizi, Zahra, et al.
Publicado: (2016)

Cardiac Conduction Defects in Systemic Lupus Erythematosus
por: Butt, Shayan, et al.
Publicado: (2020)

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
por: Núñez, Estefanía, et al.
Publicado: (2022)

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches
por: López-Pedrera, Chary, et al.
Publicado: (2010)

SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus
por: Costenbader, Karen H, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_b45s919b9e17u6bmvcengv7pnm